Search research articles
Contact Us
Filters
Showing results (51-60 of 68) with videos related to
Page
of 7
Sort By:
Ophthalmology
|
September 13, 2011
Intraoperative microscope-mounted spectral domain optical coherence tomography for evaluation of retinal anatomy during macular surgery
Robin Ray, David E Barañano, Jorge A Fortun, et al.
Journal of Cardiac Failure
|
April 25, 2017
Assessing the Eligibility Criteria in Phase III Randomized Controlled Trials of Drug Therapy in Heart Failure With Preserved Ejection Fraction: The Critical Play-Off Between a "Pure" Patient Phenotype and the Generalizability of Trial Findings
Hitesh C Patel, Carl Hayward, Jason N Dungu, et al.
BMJ Open
|
November 18, 2017
Qualitative evaluation of a deferred consent process in paediatric emergency research: a PREDICT study
Jeremy Furyk, Kristin McBain-Rigg, Kerrianne Watt, et al.
European Journal of Heart Failure
|
April 29, 2024
Multidisciplinary care of peripartum heart failure: A scientific statement of the Heart Failure Association of the ESC
Amina Rakisheva, Karen Sliwa, Johann Bauersachs, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology
|
March 19, 2011
Endothelial Nox4 NADPH oxidase enhances vasodilatation and reduces blood pressure in vivo
Robin Ray, Colin E Murdoch, Minshu Wang, et al.
Journal of Cardiac Failure
|
November 5, 2023
The Impact of Ferric Derisomaltose on Cardiovascular and Noncardiovascular Events in Patients With Anemia, Iron Deficiency, and Heart Failure With Reduced Ejection Fraction
Robin Ray, Ian Ford, John G F Cleland, et al.
Heart (British Cardiac Society)
|
February 12, 2025
Age-stratified effects of intravenous ferric derisomaltose in heart failure with iron deficiency: insights from the IRONMAN trial
Shirley Sze, Iain Squire, Paul R Kalra, et al.
European Journal of Heart Failure
|
October 25, 2024
Effect of correcting iron deficiency on the risk of serious infection in heart failure: Insights from the IRONMAN trial
Paul W Foley, Paul R Kalra, John G F Cleland, et al.
European Journal of Heart Failure
|
May 24, 2024
Differences in presentation, diagnosis and management of heart failure in women. A scientific statement of the Heart Failure Association of the ESC
Giuseppe M C Rosano, Davide Stolfo, Lisa Anderson, et al.
Lancet (London, England)
|
November 8, 2022
Intravenous ferric derisomaltose in patients with heart failure and iron deficiency in the UK (IRONMAN): an investigator-initiated, prospective, randomised, open-label, blinded-endpoint trial
Paul R Kalra, John G F Cleland, Mark C Petrie, et al.
Page
of 7
Search research articles
Search
Showing results (51-60 of 68) with videos related to
Sort By:
Page
of 7
Ophthalmology
|
September 13, 2011
Intraoperative microscope-mounted spectral domain optical coherence tomography for evaluation of retinal anatomy during macular surgery
Robin Ray, David E Barañano, Jorge A Fortun, et al.
Journal of Cardiac Failure
|
April 25, 2017
Assessing the Eligibility Criteria in Phase III Randomized Controlled Trials of Drug Therapy in Heart Failure With Preserved Ejection Fraction: The Critical Play-Off Between a "Pure" Patient Phenotype and the Generalizability of Trial Findings
Hitesh C Patel, Carl Hayward, Jason N Dungu, et al.
BMJ Open
|
November 18, 2017
Qualitative evaluation of a deferred consent process in paediatric emergency research: a PREDICT study
Jeremy Furyk, Kristin McBain-Rigg, Kerrianne Watt, et al.
European Journal of Heart Failure
|
April 29, 2024
Multidisciplinary care of peripartum heart failure: A scientific statement of the Heart Failure Association of the ESC
Amina Rakisheva, Karen Sliwa, Johann Bauersachs, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology
|
March 19, 2011
Endothelial Nox4 NADPH oxidase enhances vasodilatation and reduces blood pressure in vivo
Robin Ray, Colin E Murdoch, Minshu Wang, et al.
Journal of Cardiac Failure
|
November 5, 2023
The Impact of Ferric Derisomaltose on Cardiovascular and Noncardiovascular Events in Patients With Anemia, Iron Deficiency, and Heart Failure With Reduced Ejection Fraction
Robin Ray, Ian Ford, John G F Cleland, et al.
Heart (British Cardiac Society)
|
February 12, 2025
Age-stratified effects of intravenous ferric derisomaltose in heart failure with iron deficiency: insights from the IRONMAN trial
Shirley Sze, Iain Squire, Paul R Kalra, et al.
European Journal of Heart Failure
|
October 25, 2024
Effect of correcting iron deficiency on the risk of serious infection in heart failure: Insights from the IRONMAN trial
Paul W Foley, Paul R Kalra, John G F Cleland, et al.
European Journal of Heart Failure
|
May 24, 2024
Differences in presentation, diagnosis and management of heart failure in women. A scientific statement of the Heart Failure Association of the ESC
Giuseppe M C Rosano, Davide Stolfo, Lisa Anderson, et al.
Lancet (London, England)
|
November 8, 2022
Intravenous ferric derisomaltose in patients with heart failure and iron deficiency in the UK (IRONMAN): an investigator-initiated, prospective, randomised, open-label, blinded-endpoint trial
Paul R Kalra, John G F Cleland, Mark C Petrie, et al.
Page
of 7